Pharmaceutical Supply – Albuterol Sulfate Inhalation Aerosol

This contract involves the supply of Albuterol Sulfate Inhalation Aerosol (HFA) that is FDA-approved, adhering to the Federal Food, Drug, and Cosmetic Act (FDCA), current Good Manufacturing Practices (cGMP), and relevant federal pharmaceutical regulations. The product must have a shelf life of 24 months that is non-extendable, ensuring a reliable expiration period for medical use. The contract is designated as a subcontract under NAICS code 325412, specific to pharmaceutical manufacturing. The contract was posted by the Department of Defense's Medical Supply Chain Pharmacy Field Support Activity on May 14, 2026, with a response deadline set for May 20, 2026. While details such as solicitation number, office address, and point of contact are not provided, the procurement focuses on delivering specified quantities of this critical pharmaceutical product to support medical supply needs within the defense sector. The place of performance is unspecified, emphasizing the product and regulatory requirements as the principal elements of this procurement.